2-(3,5-Difluorophenyl)-5-(1,1-dioxo-1,2-thiazolidin-2-yl)furan-3,4-diol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 2-(3,5-Difluorophenyl)-5-(1,1-dioxo-1,2-thiazolidin-2-yl)furan-3,4-diol
• 英文别名: 2-(3,5-difluorophenyl)-5-(1,1-dioxo-1,2-thiazolidin-2-yl)furan-3,4-diol
• 化学式: C₁₃H₁₁F₂NO₅S
• 分子量: 331.29
• InChiKey: VHWOFJCWYDCDGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  99.4
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• Inhibitors of beta-hydroxylase for treatment of cancer
  申请人：MIDWESTERN UNIVERSITY

  公开号：US10106532B2

  公开（公告）日：2018-10-23

  The present invention relates to compounds which modulate (e.g., inhibit) the activity of beta-hydrolase (e.g., ASPH), including novel 2-aryl-5-amino-3(2H)-furanone and 2-heteroaryl-5-amino-3(2H)-furanone compounds, pharmaceutical compositions thereof, methods for their synthesis, and methods of using these compounds to modulate the activity of ASPH in an a cell-free sample, a cell-based assay, and in a subject. Other aspects of the invention relate to use of the compounds disclosed herein to ameliorate or treat cell proliferation disorders.

  本发明涉及调节（如抑制）β-水解酶（如ASPH）活性的化合物，包括新型2-芳基-5-氨基-3(2H)-呋喃酮和2-杂芳基-5-氨基-3(2H)-呋喃酮化合物、其药物组合物、其合成方法以及使用这些化合物调节无细胞样本、基于细胞的测定和受试者体内ASPH活性的方法。本发明的其他方面涉及使用本文公开的化合物来改善或治疗细胞增殖障碍。
• INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER
  申请人：Rhode Island Hospital

  公开号：EP2897607A2

  公开（公告）日：2015-07-29
• Inhibitors of Beta-Hydroxylase for Treatment of Cancer
  申请人：MIDWESTERN UNIVERSITY

  公开号：US20180009798A1

  公开（公告）日：2018-01-11

  The present invention relates to compounds which modulate (e.g., inhibit) the activity of beta-hydrolase (e.g., ASPH), including novel 2-aryl-5-amino-3(2H)-furanone and 2-heteroaryl-5-amino-3(2H)-furanone compounds, pharmaceutical compositions thereof, methods for their synthesis, and methods of using these compounds to modulate the activity of ASPH in an a cell-free sample, a cell-based assay, and in a subject. Other aspects of the invention relate to use of the compounds disclosed herein to ameliorate or treat cell proliferation disorders.
• [EN] INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER<br/>[FR] INHIBITEURS DE BÊTA-HYDROLASE POUR LE TRAITEMENT DU CANCER
  申请人：RHODE ISLAND HOSPITAL

  公开号：WO2014047519A2

  公开（公告）日：2014-03-27

  The present invention relates to compounds which modulate (e.g., inhibit) the activity of beta-hydrolase (e.g., ASPH), including novel 2-aryl-5-amino-3(2H)-furanone and 2- heteroaryl-5-amino-3(2H)-furanone compounds, pharmaceutical compositions thereof, methods for their synthesis, and methods of using these compounds to modulate the activity of ASPH in an a cell-free sample, a cell-based assay, and in a subject. Other aspects of the invention relate to use of the compounds disclosed herein to ameliorate or treat cell proliferation disorders.